Abstract:Diagnosing early stage Parkinson's disease (PD) is still a clinical challenge. Previous studies using iron, neuromelanin (NM) measures or the Nigrosome-1 (N1) sign in the substantia nigra (SN) by themselves have been unable to provide sufficiently high diagnostic performance for these methods to be adopted clinically. Our goal in this study was to extract the NM complex volume, iron content and volume representing the entire SN, and the N1 sign as potential complementary imaging biomarkers using a single 3D magnetization transfer contrast (MTC) gradient echo sequence and to evaluate their diagnostic performance and clinical correlations in early stage PD. A total of 40 early stage idiopathic PD subjects and 40 age- and sex-matched healthy controls (HCs) were imaged at 3T. NM boundaries (representing the SN pars compacta (SNpc) and parabrachial pigmented nucleus) and iron boundaries representing the total SN (SNpc and SN pars reticulata) were determined semi-automatically using a dynamic programming (DP) boundary detection algorithm. Receiver operating characteristic analyses were performed to evaluate the utility of these imaging biomarkers in diagnosing early stage PD. A correlation analysis was used to study the relationship between these imaging measures and the clinical scales. We also introduced the concept of NM and total iron overlap volumes to demonstrate the loss of NM relative to the iron containing SN. Furthermore, all 80 cases were evaluated for the N1 sign independently. The NM and SN volumes were lower while the iron content was higher in the SN for PD subjects compared to HCs. Interestingly, the PD subjects with bilateral loss of the N1 sign had the highest iron content. The area under the curve (AUC) values for the average of both hemispheres for single measures were: .960 for NM complex volume; .788 for total SN volume; .740 for SN iron content and .891 for the N1 sign. Combining NM complex volume with each of the following measures through binary logistic regression led to AUC values for the averaged right and left sides of: .976 for total iron content; .969 for total SN volume, .965 for overlap volume and .983 for the N1 sign. We found a negative correlation between SN volume and UPDRS-III (R2 = .22, p = .002). While the N1 sign performed well, it does not contain any information about iron content or NM quantitatively, therefore, marrying this sign with the NM and iron measures provides a better physiological explanation of what is happening when the N1 sign disappears in PD subjects. In summary, the combination of NM complex volume, SN volume, iron content and the N1 sign as derived from a single MTC sequence provides complementary information for understanding and diagnosing early stage PD.

Combination of Olfactory Test and Substantia Nigra Transcranial Sonopraphy in the Differential Diagnosis of Parkinson’s Disease: a Pilot Study from China

A Fast and Non-Invasive Artificial Intelligence Olfactory-Like System That Aids Diagnosis of Parkinson's Disease

Increased Substantia Nigra Echogenicity Correlated with Visual Hallucinations in Parkinson’s Disease: a Chinese Population-Based Study

Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease

The Role of Substantia Nigra Sonography in the Differentiation of Parkinson's Disease and Multiple System Atrophy

Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson's disease and its clinical implications

Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's Disease: A Systematic Review and Meta-analysis.

Substantia Nigra Echogenicity Correlated with Clinical Features of Parkinson's Disease

Olfactory functional covariance connectivity in Parkinson’s disease: Evidence from a Chinese population

Sensitivity of Sniffer Dogs for a Diagnosis of Parkinson's Disease: A Diagnostic Accuracy Study.

Application of Odor Identification Test in Parkinson's Disease in China: A Matched Case-Control Study

Olfactory Function in Chinese Parkinson's Disease Patients: an Event-Related Fmri Study

Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease

Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease

The Predictive Value of SS-16 in Clinically Diagnosed Parkinson’s Disease Patients: Comparison with 99m Tc-TRODAT-1 SPECT Scans

Neuroimaging Characteristics of Transcranial Sonography in Parkinson's Disease Patients with Depression

Investigating the Role of 99Mtc-Trodat-1 SPECT Imaging in Idiopathic Parkinson's Disease.

A Multiple-Tissue-specific Magnetic Resonance Imaging Model for Diagnosing Parkinson's Disease: a Brain Radiomics Study.

Transcranial sonography in patients with Parkinson disease and Alzheimer disease

Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and de novo Parkinson's Disease.

Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the nigrosome-1 sign as complementary imaging biomarkers in early stage Parkinson's disease